HOLLISTON, Mass. , April 23, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its first quarter 2019 after market trading hours on Thursday, May 2, 2019 .
Company Receives Honor at Business Transformation & Operational Excellence Industry Awards 2019 in Orlando, Florida HOLLISTON, Mass. , April 03, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a division of Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and
All Three Commercial Units to Be Represented HOLLISTON, Mass. , March 26, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting new laboratory products and applications for
-Reports record Fourth Quarter GAAP and adjusted non-GAAP revenue of $33.9 million, a year-over-year increase of 56% and 24%, respectively- HOLLISTON, Mass. , Feb. 28, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of
Company To Sponsor Session on Novel Approaches for Respiratory Measurement, Showcase Portfolio of Instrumentation Products and Solutions and Present Data HOLLISTON, Mass. , Feb. 26, 2019 (GLOBE NEWSWIRE) -- Data Sciences International (DSI), a subsidiary of Harvard Bioscience , Inc. (Nasdaq: HBIO),
HOLLISTON, Mass. , Feb. 19, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its fourth quarter 2018 after market trading hours on Thursday, February 28,
HOLLISTON, Mass. , Nov. 02, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, is presenting its new neuroscience products and applications for preclinical life science research at
-Reports GAAP and adjusted non-GAAP revenue of $28.6 million and $28.7 million , respectively, an increase of 53% and 15%, respectively- HOLLISTON, Mass. , Oct. 25, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a
Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass. , Oct. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience , Inc. (Nasdaq: HBIO) (the “Company”), a global developer, manufacturer and marketer of a broad range of
HOLLISTON, Mass. , Oct. 18, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO), a global developer, manufacturer and marketer of a broad range of solutions to advance life science, will announce results for its third quarter 2018 after market trading hours on Thursday, October 25,
